Navigation Links
Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:4/26/2008

>

2 SVR, the protocol specified primary efficacy endpoint, is defined as

achievement of undetectable HCV-RNA in plasma at 24 weeks after the end

of treatment. Per protocol, if a patient did not have a 24-week post-

treatment assessment, the patient's 12-week post-treatment assessment

was utilized.

3 Roche Cobas Taqman 1.0 assay; lower limit of quantitation (LLQ) is 27

IU/mL.

4 Intention-To-Treat (ITT) analysis includes any patient who has taken at

least one dose of any study drug.

5 Sensitivity Analysis: Patients with missing data at follow-up week 24

are included in the analysis if treatment week 4 and treatment week 24

undetectable (HCV-RNA): PPVs at treatment week 4 were 94 vs. 91 vs. 89

percent for the PEGINTRON 1.5 mcg arm, PEGINTRON 1.0 mcg arm and Pegasys

arm, respectively.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
3. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
4. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
11. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... /PRNewswire-iReach/ -- 9 th Annual FDA Inspections Summit ... Bethesda, MD Early Bird Registration discount ends ... Photo - http://photos.prnewswire.com/prnh/20140912/145652 What ... to get a glimpse into the inner workings of ... Come to Washington ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 ... addition of the "Global Medical Technologies Market ... Medical technology is a collective term for ... used to ensure good health. The Global Medical ... anaesthetic and respiratory technology, In vitro diagnostics technology, ...
(Date:9/12/2014)...  Genomic Health, Inc. (Nasdaq: GHDX ) ... from a health economic analysis suggesting that use of ... a significant reduction in direct medical costs and improve ... effects of unnecessary treatment.  "By providing ... measures, as demonstrated in this analysis, the Oncotype DX ...
Breaking Medicine Technology:FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 2Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 4Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 5
(Date:9/14/2014)... 14, 2014 Top10BestSEOHosting.com always offers ... many web host suppliers carefully, the site has ... GoDaddy are the Best WordPress Hosting suppliers in ... as a top web hosting provider, and the ... a web hosting provider known for its flexible ...
(Date:9/14/2014)... September 14, 2014 UWDress.com, is an ... industry, has recently announced its new range of ... and bring more benefits to worldwide ladies, the company ... including lace wedding outfits, blue evening gowns, black formal ... to 70 percent off. , The company’s senior ...
(Date:9/13/2014)... BC (PRWEB) September 13, 2014 ... Center, a renowned Vancouver chiropractic clinic, has recently ... medicine. In this latest blog on the topic, ... and clarified several myths that people have regarding ... difference between the services of a chiropractor and ...
(Date:9/13/2014)... Researchers say they,ve tracked specific activity in the human ... whether imagination and memory were distinct processes, so a ... to explore the issue. "I was thinking a ... myself in the future, and I started wondering how ... said in a university news release. "I wondered ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Top10BestSEOHosting.com ... has recently compared a lot of web hosting ... Hostgator and Arvixe are the best ASP.NET hosting ... of Top10BestSEOHosting.com, ASP.NET hosting is a very popular ... XML websites. , The IT manager is happy ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2
... of Australias leading life scientists have been chosen from ... in an initiative by Merck Sharp & Dohme and ... biopharmaceutical industry. , Antisense Therapeutics Ltd (ASX code: ... Director Dr Raisa Monteiro have been selected as joint ...
... properties of bitter melon, a vegetable and traditional Chinese ... 2 diabetes. , Teams from the Garvan Institute of ... pulped roughly a tonne of fresh bitter melon and ... all appear to activate the enzyme AMPK, a protein ...
... Cowden Associates Finds High-Deductible Health Plans Not the Solution for ... ... 27 Employers in Pennsylvania, West,Virginia and Ohio believe the future ... health through wellness programs,according to Cowden Associates, Inc. Seventh Annual Tri-State ...
... 27 Ethicon Endo-Surgery announced,today that the ... application,to the U.S. Food and Drug Administration ... personalized sedation (CAPS) system., The SEDASYS(TM) ... teams to,administer minimal to moderate propofol sedation ...
... Software Introduces Comprehensive Patient and Information Tracking System with Automatic ... ... DALLAS, March 27 Eklin Medical Systems, a leading,developer of digital ... for veterinary care,(VIA(R)), is showcasing VIA,s new Hospital Functionality and VIA ...
... their children are often involved in caring ... -- Alzheimer,s care in the United States is a ... five so-called "sandwich" caregivers who look after a relative ... with care duties, ranging from attending doctors, appointments to ...
Cached Medicine News:Health News:Rising Australian biotech stars set to connect on the world stage 2Health News:A ton of bitter melon produces sweet results for diabetes 2Health News:Survey Highlights Ongoing Shift To Wellness to Manage Health Care Costs 2Health News:Survey Highlights Ongoing Shift To Wellness to Manage Health Care Costs 3Health News:Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3Health News:With Alzheimer's, It Takes a Family 2Health News:With Alzheimer's, It Takes a Family 3
... continues to raise the standard for rapid, ... x g performance and our new 4x5mL ... sizes from 0.2 ml to 8.3 ml, ... drive, very quiet operation, rotor imbalance detection, ...
... has the highest g-force ever. But optimal ... force. Optima MAX combines maximum force, capacity, ... performance that's worlds apart from any other ... and enhanced efficiency, Optima takes productivity to ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
... of generating 694,000 x g ... rpm, Beckman Coulter's Optima L-90K ... more separations in less time. ... with a broad range of ...
Medicine Products: